The Hospital-Treated Gram-Negative Infections Market is poised for steady expansion over the coming decade, driven by the growing burden of antimicrobial resistance, increasing hospital admissions, and rising demand for advanced anti-infective therapies. Gram-negative pathogens such as Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii are among the...